title: Merck: An Undervalued Stock In An Expensive Market
source: SeekingAlpha
date: 2025-10-13
url: https://finnhub.io/api/news?id=a08cab6ce3479041e6c9f2e6a8cbb31a0561475197938fb4f299be686895d090
Merck increased its revenue from $39.5 billion in FY 2015 to $64.2 billion in FY 2024. Thatâs a compound annual growth rate of 5.5%. See why I rate MRK stock a buy.
